These and other GnRH experimental agonists have been also studied in a wide variety of different diseases, involving uterine fibroids, ovarian polycystic disease, fibrocystic breast, benign bowel, and prostatic hypertrophy. This evidence concerns the gene GNRH1 and polycystic ovary syndrome.